3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 3
1
Phase 1/2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Multiple Myeloma
11
Neoplasms
8
Vomiting
6
Nausea
5
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Neoplasm, Residual
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Wrist Fractures
1
Systemic Inflammatory Response Syndrome
1
Supratentorial Neoplasms
1
Radicular Cyst
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Mediastinal Neoplasms
1
Malnutrition
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Bupivacaine
10
Saline Solution
5
Ropivacaine
5
Sodium Chloride
4
Dexmedetomidine
4
Lidocaine
3
Acetaminophen
3
Tramadol
2
Pregabalin
2
Morphine
2
Ketorolac
2
Ketamine
2
Gabapentin
2
Dexamethasone
2
Anti-Inflammatory Agents, Non-Steroidal
2
Analgesia, Epidural
2
oxycodone-acetaminophen
1
gamma-Aminobutyric Acid
1
Vitamins
1
Sufentanil
1
Spinal Puncture
1
Propofol
1
Population Groups
1
Orphenadrine
1
Neck Dissection
1
Myelography
1
MoxDuo
1
Midazolam
1
Methadone
1
Meloxicam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Pain, Postoperative
×
Dexamethasone
×
Clear all
NCT06787196
2025-05-13
DXM-PAIN
Selcuk University
Phase 4
Completed
60 enrolled
NCT03125941
2019-12-02
DEX-MAS
Rigshospitalet, Denmark
Phase 4
Completed
130 enrolled
20 charts